Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

TRDATRDA
14 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in ENTRADA THERAPEUTICS INC

CITADEL ADVISORS LLC holds 394,323 shares of TRDA (ENTRADA THERAPEUTICS INC), worth $2.9M as of 2026-Q2. The position was increased (+83.4% shares). TRDA represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$2.9M

Current Shares

394,323

Total Value Change

+$1M

Total Shares Change

+285,529

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
394,323
+83.4%
$2.9M0.0%$7.36
41
2026-Q1
Decreased
215,018
-26.6%
$2.7M0.0%$11.85
0
2025-Q4
Decreased
292,770
-12.8%
$3M0.0%$10.09
0
2025-Q3
Increased
335,741
+234.6%
$1.9M0.0%$5.84
42
2025-Q2
Increased
100,357
+510.0%
$674,3990.0%$6.91
40
2025-Q1
Decreased
16,453
-76.7%
$148,7350.0%$9.56
0
2024-Q4
Decreased
70,669
-19.9%
$1.2M0.0%$17.37
0
2024-Q3
Decreased
88,224
-32.4%
$1.4M0.0%$16.45
0
2024-Q2
Increased
130,449
+87.2%
$1.9M0.0%$14.25
40
2024-Q1
New
69,676
-
$987,3090.0%$14.17
35
2022-Q3
Exited
0
-100.0%
$00.0%$15.54
0
2022-Q2
Decreased
12,947
-79.9%
$158,0000.0%$12.94
0
2022-Q1
Decreased
64,399
-40.8%
$604,0000.0%$9.55
0
2021-Q4
New
108,794
-
$1.9M0.0%$18.37
36

Other major holders of TRDA: BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used